Rocky Mountain Benekli Humması

Alhassan A, Liu H, McGill J, et al. Rickettsia rickettsii whole-cell antigens offer protection against Rocky Mountain spotted fever in the canine host. Infection and Immunity. 2019;87(2):e00628-18. doi:10.1128/IAI.00628-18

Álvarez-Hernández G, Roldán JFG, Milan NSH, et al. Rocky Mountain spotted fever in Mexico: Past, present, and future. The Lancet Infectious Diseases. 2017;17(6):e189-e196. doi:10.1016/S1473-3099(17)30173-1

Álvarez-López DI, Ochoa-Mora E, Nichols Heitman K, et al. Epidemiology and clinical features of Rocky Mountain spotted fever from enhanced surveillance, Sonora, Mexico: 2015-2018. American Journal of Tropical Medicine and Hygiene. 2021;104(1):190-197. doi:10.4269/ajtmh.20-0854

Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis-United States. MMWR Recommendations and Reports. 2016;65(2):1-44. doi:10.15585/mmwr.rr6502a1

Breitschwerdt EB, Davidson MG, Aucoin DP, et al. Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrobial Agents and Chemotherapy. 1991;35(11):2375-2381. doi:10.1128/AAC.35.11.2375

Breitschwerdt EB, Davidson MG, Hegarty BC, et al. Prednisolone at anti-inflammatory or immunosuppressive dosages in conjunction with doxycycline does not potentiate the severity of Rickettsia rickettsii infection in dogs. Antimicrobial Agents and Chemotherapy. 1997;41(1):141-147. doi:10.1128/AAC.41.1.141

Breitschwerdt EB, Walker DH, Levy MG, et al. Clinical, hematologic, and humoral immune response in female dogs inoculated with Rickettsia rickettsii and Rickettsia montana. American Journal of Veterinary Research. 1988;49(1):70-76.

Dantas-Torres F. Rocky Mountain spotted fever. The Lancet Infectious Diseases. 2007;7(11):724-732. doi:10.1016/S1473-3099(07)70261-X

Demma LJ, Traeger M, Blau D, et al. Serologic evidence for exposure to Rickettsia rickettsii in eastern Arizona and recent emergence of Rocky Mountain spotted fever in this region. Vector-Borne and Zoonotic Diseases. 2006;6(4):423-429. doi:10.1089/vbz.2006.6.423

Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. New England Journal of Medicine. 2005;353(6):587-594. doi:10.1056/NEJMoa050043

Estripeaut D, Aramburú MG, Sáez-Llorens X, et al. Rocky Mountain spotted fever, Panama. Emerging Infectious Diseases. 2007;13(11):1763-1765. doi:10.3201/eid1311.070931

Gasser A, Birkenheuer A, Breitschwerdt E. Canine Rocky Mountain spotted fever: A retrospective study of 30 cases. Journal of the American Animal Hospital Association. 2001;37(1):41-48. doi:10.5326/15473317-37-1-41

Harrus S, Waner T, Aizenberg I, Bark H. Therapeutic effect of doxycycline in experimental subclinical canine monocytic ehrlichiosis: Evaluation of a 6-week course. Journal of Clinical Microbiology. 1998;36(7):2140-2142. doi:10.1128/JCM.36.7.2140-2142.1998

Holman RC, Paddock CD, Curns AT, et al. Analysis of risk factors for fatal Rocky Mountain spotted fever: Evidence for superiority of tetracyclines for therapy. Journal of Infectious Diseases. 2001;184(11):1437-1444. doi:10.1086/324372

Pieracci EG, De La Rosa JDP, Rubio DL, et al. Seroprevalence of spotted fever group rickettsiae in canines along the United States-Mexico border. Zoonoses and Public Health. 2019;66(8):918-926. doi:10.1111/zph.12642

Snowden J, Simonsen KA. Rocky Mountain spotted fever (Rickettsia rickettsii). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025.

Thompson MS. Clinical signs approach to differential diagnosis. In: Small animal medical differential diagnosis. St. Louis: Elsevier; 2018. p.1-85. doi:10.1016/B978-0-323-49830-2.00001-9

Walker DH, Blanton LS, Laroche M, et al. A vaccine for canine Rocky Mountain spotted fever: An unmet One Health need. Vaccines. 2022;10(10):1626. doi:10.3390/vaccines10101626

Walker DH. Rickettsiae and rickettsial infections: The current state of knowledge. Clinical Infectious Diseases. 2007;45(Suppl 1):S39-S44. doi:10.1086/518145